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astinal, and abdominal lymph nodes) improves the sur-
vival of patients with carcinoma of the thoracic esopha-
gus.2,3 Recently, Altorki and Skinner4 reported that cer-
vical node metastases are early events in carcinoma of
the esophagus. Although that report suggested the effi-
cacy and necessity of 3-field dissection for the treat-
ment of carcinoma of the esophagus, the benefit of 3-
field dissection remains controversial. In fact Orringer
and Sloan5 and Gupta6 stressed the superiority of
esophagectomy without thoracotomy for carcinoma of
the thoracic esophagus because of its low morbidity and
mortality rates. They pointed out that severe complica-
tions may result from 3-field dissection, especially
recurrent nerve palsy caused by the dissection of recur-
rent nerve nodes. Some surgeons have reported a high
incidence (70%) of recurrent nerve injury after 3-field
dissection.7 This potential morbidity emphasizes the
importance of determining which patients are most like-
ly to benefit from 3-field dissection.
B ecause carcinoma of the thoracic esophagus ofteninvolves not only mediastinal lymph nodes but also
cervical and abdominal lymph nodes and has a high
incidence of locoregional recurrence after radical
esophagectomy, long-term survivals are low. For this
reason, attempts at en bloc resection of the esophagus
have been carried out.1 In this decade Japanese sur-
geons have postulated that 3-field lymphadenectomy
(3-field dissection including bilateral cervical, medi-
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The number of positive nodes has previously been
reported to be an important prognostic factor in carci-
noma of the esophagus.8 This parameter is useful in
staging esophageal carcinoma. There has been no study
regarding the indication for 3-field dissection in the
presence of lymph node metastases, especially with
reference to the sites of nodal involvement and the
number of positive nodes. The aim of this retrospective
study was to evaluate the efficacy of 3-field dissection
for advanced carcinoma of the thoracic esophagus and
to clarify the indication for this procedure with respect
to the presence of lymph node metastasis.
Patients and methods
From January 1983 to December 1995, 238 patients with
squamous cell carcinoma of the thoracic esophagus under-
went esophagectomy at Kumamoto University Hospital,
Kumamoto, Japan. Among these 238 patients, this retrospec-
tive observational study evaluated the 86 who underwent
curative esophagectomy with lymph node dissection through
a right thoracotomy for tumors classified as pT2 to pT4 in the
TNM staging system (International Union Against Cancer).9
All of the 86 patients studied received preoperative and post-
operative chemotherapy, including cisplatin and 5-fluo-
rouracil. Of the 86 patients, 19 patients had disease catego-
rized as pT2, 62 had disease categorized as pT3, and 5 had
disease categorized as pT4. Among the 5 patients with pT4
disease, 2 had tumors invading the pericardium, 2 had tumors
invading the thoracic duct, and 1 had a tumor invading lung
and pericardium. These 5 patients underwent en bloc
esophagectomy including invaded adjacent structures (R0 in
the TNM classification). Of the 86 patients, 46 underwent a 2-
field dissection including mediastinal and abdominal lymph
nodes (group A) and 40 underwent a 3-field dissection includ-
ing bilateral cervical, mediastinal, and abdominal nodes
(group B). Seven patients who underwent “pick up” dissection
of cervical nodes were included in group A, as reported by
Isono and colleagues.2 As a principle, 3-field dissection was
not performed in patients who were older than 75 years or had
any comorbid diseases, such as diabetes mellitus and liver cir-
rhosis. Four patients in group A had comorbid diseases; 2 had
diabetes mellitus without organ failure and 2 had liver cirrho-
sis. In group B, only 1 patient had mild diabetes mellitus. No
patients in this series had any other comorbid diseases.
Subtotal esophagectomy through a right thoracotomy at the
fifth intercostal space was performed as described previous-
ly.10 In brief, periesophageal nodes, bilateral intrathoracic
recurrent nerve chain nodes, infracarinal nodes, and infra-
aortic arch nodes were resected through a right thoracotomy.
If 3-field dissection was chosen, bilateral cervical recurrent
laryngeal nerve chain nodes, internal jugular nodes, and supra-
clavicular nodes were dissected in the area from the upper
level of thyroid cartilage to the supraclavicular area with
bilateral skin collar incisions. After 2- or 3-field dissection,
reconstruction was carried out by esophagogastrostomy or
esophagocolostomy in the left side of the neck.
Follow-up was complete for all patients until the end of the
study or their death. The statuses of all patients were verified
by direct contact, mail, or telephone from the patients or their
families at least annually. A follow-up duration of 0 was
defined as the date of esophagectomy. The duration of post-
operative follow-up ranged from 1 to 144 months, with a
mean duration of 41.9 months. The mean durations of groups
A and B were both 41.9 months.
After further grouping patients according to the number of
positive nodes, metastases to mediastinal lymph nodes, and
metastases to recurrent nerve chain nodes, survival curves for
groups A and B were compared. In addition, survivals within
group B were compared after stratification according to cer-
vical nodal involvement. In group B the relationship between
total number of positive nodes and number of positive non-
cervical nodes in patients with cervical node metastasis was
examined. Potential prognostic factors in predicting long-
term survival of these 86 patients were evaluated by means of
the Cox proportional hazards regression model. Age, sex
ratio, and the number of positive nodes in groups A and B
were compared with the unpaired Student t test. The relative
frequencies of tumor location and pT, pN, and pM statuses
were compared with the c 2 test. Survival curves and 3- and 5-
year survival rates were obtained according to the method of
Kaplan and Meier. Comparison of survival curves was carried
out with the generalized Wilcoxon test. Statistical calcula-
tions were conducted with Stat View (Abacus Concepts Inc,
Berkeley, Calif).
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Table I. Characteristics of 86 patients with locally
advanced squamous cell carcinoma of the esophagus
Group A Group B 
(2-field dissection, (3-field dissection,
n = 46) n = 40) P
Age (y, mean ± SD) 64.6 ± 9.6 61.2 ± 9.1 .10
Gender .97
Male 37 33
Female 9 7
Tumor location .52
Upper 1 2
Middle 29 28
Lower 16 10
T category .12
pT2 14 5
pT3 29 33
pT4 3 2
N category .39
pN0 14 8
pN1 32 32
M category .08
pM0 41 30
pM1 5 10
No. of positive nodes 3.4 ± 4.5 4.4 ± 5.6 .50
(mean ± SD)
Results
Patient characteristics. The patient characteristics
of the 2 groups are shown in Table I. The mean ages;
the sex ratios (male/female); the distribution of tumor
locations; the pT, pN, and pM categories; and the mean
number of positive nodes were not significantly differ-
ent between the 2 groups.
Survivals and number of positive nodes. The 3-
year and 5-year survivals were 37% and 24%, respec-
tively, for group A and 45% and 42%, respectively, for
group B. No significant difference was seen between
the 2 survival curves (P = .18; Fig 1). In the subgroup
without lymph node metastasis (pN0), the 3-and 5-
year survivals were 57% and 43%, respectively, for
group A (n = 14) and both 38% for group B (n = 7).
No significant difference was seen between the 2 sur-
vival curves (P = .48). In the subgroup with 1 to 4
positive nodes, the 3-and 5-year survivals were 28%
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Fig 1. Survival curves of all patients in groups A and B. No significant difference was seen.
Fig 2. Survival curves of patients with 1 to 4 positive nodes in groups A and B. The vertical bars represent the
95% confidence interval. A significant difference is seen between the 2 curves.
and 22%, respectively, for group A (n = 18) and both
54% for group B (n = 23). Comparison of the 2 sur-
vival curves yielded a significant difference (P = .01;
Fig 2). In the subgroup with 5 or more positive nodes,
the 3- and 5-year survivals were 21% and 7%, respec-
tively, for group A (n = 14) and 30%and 20%, respec-
tively, for group B (n = 10). There was no significant
difference between the 2 survival curves.
Survivals among patients with positive intratho-
racic nodes. Forty-nine of the 86 patients had positive
intrathoracic nodes. In this subgroup, the 3- and 5-year
survivals were 25% and 13%, respectively, for group A
(n = 24) and 46% and 42%, respectively, for group B (n
= 25). There was a significant difference between the 2
survival curves (P = .02; Fig 3).
Survivals among patients with positive intratho-
racic recurrent nerve chain nodes. Twenty-five
patients had positive intrathoracic recurrent nerve chain
nodes. Patients with positive pretracheal or right para-
tracheal nodes also were included in this group. The 3-
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Fig 3. Survival curves of patients with positive intrathoracic nodes in groups A and B. The vertical bars repre-
sent the 95% confidence interval. A significant difference is seen between the 2 curves.
Fig. 4. Survival curves of patients with or without positive cervical nodes who underwent 3-field dissection. No
significant difference was seen. CN, Cervical nodes.
and 5-year survivals were 10% and 0%, respectively,
for group A (n = 10) and 40% and 33%, respectively,
for group B (n = 15). No significant difference was
seen between the 2 survival curves (P = .15).
Survivals among patients with positive cervical
lymph nodes. In group B, 12 of 40 patients had cervical
lymph node metastases. The 3- and 5-year survivals
were 50% and 42%, respectively, for patients with cervi-
cal nodal metastases and both 42% for patients without
cervical nodal metastases. No significant difference was
seen between the 2 survival curves (P = .98; Fig 4).
Relationship between total number of positive
nodes and number of positive noncervical nodes in
patients with cervical node metastases who under-
went 3-field dissection. Table II shows total numbers
of positive nodes, numbers of positive cervical nodes,
and numbers of positive extracervical nodes (mediasti-
nal and abdominal nodes) in 12 patients in group B
with cervical nodal involvement. Of these 12 patients,
7 patients had 1 to 4 positive nodes and 5 patients had
5 or more positive nodes. Of the 7 patients with 1 to 4
positive nodes, 6 patients had 1 to 4 positive nodes in
extracervical regions (cases 2-7). Of the 5 patients with
5 or more positive nodes, all had 5 or more positive
nodes in extracervical regions (cases 8-12).
Multivariate analysis. The Cox proportional haz-
ards regression model was used to evaluate potential
prognostic factors of these 86 patients. Age, sex,
comorbidity, tumor location, pT, pN, pM, positive
intrathoracic nodes, positive recurrent nerve chain
nodes, the number of positive nodes, and 3-field dis-
section were selected as variables for this analysis.
Age, pT4, and the number of positive nodes were
selected to be significantly predictive of survival after
esophagectomy (Table III). The number of positive
nodes was thought to be the most strongly predictive
because of its P value (P = .0002).
Discussion
In this study 3-field dissection improved the survival of
patients with positive intrathoracic nodes and with 1 to 4
positive nodes but not that of patients without involved
nodes (pN0) or with 5 or more positive nodes. The mul-
tivariate analysis revealed that the number of positive
nodes was a potential prognostic factor. These data sug-
gest that the number of positive nodes could be used as
an indication for the performance of a 3-field dissection.
The depth of tumor infiltration, as well as lymph node
spread, is a potential prognostic factor of esophageal can-
cer.11 Our analysis showed that pT4 cancer was also a
significant predictor. Tumors invading to adjacent organs
may be beyond the effect of 3-field dissection, even if
they could be resected grossly completely.
Age was also a significant prognostic factor in tho-
racic esophageal carcinoma. This implies that the indi-
cation for 3-field dissection may be regulated by
patient’s age. In fact, it is reported that high mortality
rates have been found among elderly patients undergo-
ing 3-field dissection.12
Many surgeons, especially in Japan, have reported
that 3-field dissection improves the prognosis associat-
ed with carcinoma of the esophagus compared with 2-
field dissection2,3,13; however, no study has addressed
the benefit of 3-field dissection with respect to 2-field
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Table II. Relationship of total number of positive
nodes and number of positive extracervical nodes in
patients with positive cervical nodes who underwent
3-field dissection
Case Total No. of No. of No. of 
No. positive nodes CNs ECNs
1 1 1 0
2 3 2 1
3 3 1 2
4 4 2 2
5 4 1 3
6 4 1 3
7 4 1 3
8 6 1 5
9 9 1 8
10 10 1 9
11 12 2 10
12 31 7 24
CNs, Cervical nodes; ECNs, extracervical nodes.
Table III. Results of Cox regression analysis for
survival in thoracic esophageal carcinoma
Variable Hazard ratio 95% CI P
Sex (male) 1.23 0.58-2.60 .6
Age 1.04 1.01-1.07 .02
Comorbid diseases 0.85 0.28-2.61 .8
Tumor location
Upper third 2.07 0.38-11.32 .4
Middle third 2.18 0.42-11.18 .4
T category
pT4 4.10 1.29-13.10 .02
pT3 0.94 0.46-1.93 .9
N category
pN1 0.72 0.28-1.85 .5
M category
pM1 0.95 0.43-2.10 .9
Positive intrathoracic nodes 1.31 0.51-3.36 .6
Positive RCNs 0.95 0.45-1.97 .9
No. of positive nodes 1.13 1.06-1.20 .0002
3-field dissection 0.57 0.31-1.07 .08
CI, Confidence interval; RCNs, recurrent nerve chain nodes.
dissection in terms of the number of positive nodes. Ide
and coworkers14 reported no significant difference in
survival between patients with node-negative (pN0)
disease who underwent 2- and 3-field dissections. This
finding is consistent with our results.
In this study no significant difference between the 2-
and 3-field groups was seen in the survivals of patients
with positive cervical nodes. The mean number of pos-
itive nodes in patients with cervical nodal involvement
was 6.5 (data not shown). Siewert and colleagues15
reported a poor prognosis in patients with 5 or more
positive nodes. In a study by Skinner and associates,11
penetration though the esophageal wall and lymph
node spread were the only factors that influenced sur-
vival, and patients with 5 or more positive nodes had a
very poor prognosis after en bloc resection. Huang and
Sun16 reported that the 5-year survival of patients with
fewer than 5 positive nodes was significantly higher
than that of patients with 5 or more positive nodes.
Baba and coworkers12 reported that the 5-year survival
for patients with 6 or more metastatic nodes was 7.2%,
even after 3-field dissection. These results are consis-
tent with our findings and suggest that 3-field dissec-
tion is not indicated for
. 
patients with 5 or more positive
nodes, probably because these patients already have
systemic disease. Also, our result showed no difference
in survival between the 2 groups with cervical nodal
involvement. We reported previously that the survival
of patients with positive nodes limited to the recurrent
laryngeal nerve chain was better than that of patients
with positive internal jugular nodes, including supra-
clavicular nodes. We concluded that this was because
there were more patients with 5 or more positive nodes
who had positive internal jugular nodes than who had
positive nodes limited to the recurrent laryngeal nerve
chain.10 These data support our belief that cervical
nodal involvement is not a contraindication to 3-field
dissection. Recently, identifiable tumor cells in lymph
nodes were detected in half of the patients who were
considered free of lymph node metastases according to
histopathologic analysis after curative en bloc
esophagectomy for esophageal cancer.17 Our results
and those in this report suggest that the addition of cer-
vical node dissection would be beneficial in patients
with occult cervical lymph nodes.
Although our multivariate analysis did not find sig-
nificance in recurrent nerve chain involvement, includ-
ing pretracheal and right paratracheal nodes, there were
no 5-year survivors with positive recurrent nerve chain
nodes after 2-field dissection. Kutsuna18 reported that
upper mediastinal lymph flow drains mainly into the
right cervical lymph nodes. The intrathoracic right
recurrent nerve chain nodes were involved in 34.3% of
patients who underwent 3-field dissection, as described
previously.19 The significance of 3-field dissection to
patients with recurrent nerve chain nodal involvement
should be studied further.
It is possible that patients with 1 to 4 positive nodes
in group A actually might have had many more positive
nodes than were noted, because they did not undergo
cervical dissection, and the improved survival seen in
this subset was therefore not due to the performance of
3-field dissection. As mentioned previously, however,
no patient with 1 to 4 positive extracervical nodes in
group B had 5 or more positive nodes total, and only 1
of the 12 patients with positive cervical nodes in group
B (case 1) had the disease “upstaged” as a consequence
of the addition of cervical node dissection (Table II).
We do not think that there was stage migration in our
series.
Three-field dissection for advanced carcinoma of the
thoracic esophagus should be limited to patients with 1
to 4 positive nodes. Elderly patients and patients with
tumors invading to adjacent structures should especial-
ly be excluded from the indication. The clinical strate-
gy derived from these results is as follows. Endoscopic
ultrasonography can be used to diagnose depth of
tumor infiltrations and lymph node metastases, and its
accuracy is 100% in the preoperative evaluation of
esophageal tumors.20 Our current criteria of lymph
node metastases in preoperative ultrasonography and
endoscopic ultrasonography are as follows: (1) hypo-
echoic pattern and well-demarcated margins, (2) glob-
ular shape of lymph node, not flat, and (3) diameter of
lymph node larger than 5 mm. The accuracy of this
assessment is not perfect, however, because the detec-
tive rate of endoscopic ultrasonography is still low in
the bilateral recurrent nerve chain nodes. If the preop-
eratively determined number of positive nodes is 1 to 4
according to these criteria, 3-field dissection is chosen.
If preoperative images reveal “bulky” lymph nodes,
which implies advanced lymph nodal involvement in
many cases, 3-field dissection is not indicated but adju-
vant radiochemotherapy is introduced.
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